Intuitive Surgical Reports Q3 2024 Financial Results

Intuitive Surgical has released its financial results for the third quarter of 2024. The company reported an increase in the number of surgical robot system installations and procedure volumes during the period. Revenues grew compared to the same quarter last year, and the company's profitability ratios showed an improving trend. Management noted that global demand for da Vinci surgical systems remains strong, and strategies to enter new markets are yielding positive results. Particularly noteworthy was the increase in procedure volumes in the Asia-Pacific region. Additionally, the company emphasized that its R&D spending is focused on next-generation robotic surgery technologies. Controlled growth in operating expenses supported the company's net profit margin. Intuitive Surgical continues to take steps to enhance shareholder value while maintaining its cash flow generation capacity. The company also revised its procedure volume growth expectations for the end of 2024 upward. The financial results indicate that the company maintains its competitive advantage in the healthcare sector and reinforces its leadership position in the robotic surgery market. Investors have responded positively to the company's growth potential and innovation capability, with stock performance reflecting this optimistic sentiment. This is not investment advice.